Mottiwala Aziz

CIK 00017885422 companiesIRVINE, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001788542

Recent Transactions

48 trades

Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-06-09$43.76/sh−17,500→ 47,557 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-03-20$50.11/sh−3,365→ 65,057 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-03-19$47.40/sh−3,557→ 68,422 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-03-18$46.29/sh−3,643→ 71,979 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2025-03-15+20,957→ 75,622 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-03-15−4,790→ 4,790 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-03-15−8,148→ 16,296 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-03-15−8,019→ 24,060 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2025-03-05+33,691→ 33,691 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2025-03-05+22,098→ 22,098 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2024-03-18$30.60/sh−4,766→ 54,075 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2024-03-15+12,938→ 58,841 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2024-03-15−4,790→ 9,580 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2024-03-15−8,148→ 24,444 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2024-03-07+47,500→ 47,500 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2024-03-07+32,079→ 32,079 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-07-19$20.05/sh−2,400→ 45,806 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-06-08$20.00/sh−100→ 48,086 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-06-07$19.34/sh−2,500→ 48,186 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-06-06$18.61/sh−2,143→ 50,686 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-03-23$12.15/sh−372→ 52,829 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-03-22$12.64/sh−357→ 53,201 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-03-21$12.89/sh−349→ 53,558 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-03-20$12.61/sh−358→ 53,907 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-03-17$13.28/sh−339→ 54,265 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-03-16$13.43/sh−336→ 54,604 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2023-03-15−4,790→ 14,370 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2023-03-15+4,790→ 54,940 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2023-03-08+48,116→ 48,116 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2023-03-08+32,592→ 32,592 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2022-11-15$17.72/sh−6,857→ 49,729 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2022-08-24$10.99/sh+4,416→ 55,814 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Employee Stock Option (right to buy)
2022-08-24$10.99/sh−4,416→ 10,573 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Employee Stock Option (right to buy)
2022-08-24$0.45/sh−772→ 0 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2022-08-24$0.45/sh+772→ 56,586 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Restricted Stock Units
2022-03-09+19,160→ 19,160 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2022-03-09+65,312→ 65,312 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2021-11-08$28.11/sh−1,889→ 50,203 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2021-11-05$28.11/sh−11→ 52,092 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2021-11-04$28.03/sh−100→ 52,103 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2021-11-02$27.07/sh−542→ 52,203 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2021-11-02$26.75/sh−5,458→ 52,745 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Employee Stock Option (right to buy)
2021-09-10$10.99/sh−4,350→ 14,989 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2021-09-10$10.99/sh+4,350→ 58,203 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2021-09-10$0.45/sh+2,593→ 60,796 total
Exercise/Conversion
Tarsus Pharmaceuticals, Inc.$TARS
Employee Stock Option (right to buy)
2021-09-10$0.45/sh−2,593→ 772 total
Sale
Tarsus Pharmaceuticals, Inc.$TARS
Common Stock
2021-09-10$22.15/sh−2,593→ 58,203 total
Award
Tarsus Pharmaceuticals, Inc.$TARS
Stock Option (right to buy)
2021-01-07+40,999→ 40,999 total

Companies

Recent Filings

Address

C/O TARSUS PHARMACEUTICALS, INC. 15440 LAGUNA CANYON ROAD, SUITE 160

IRVINE, CA, 92618

View on SEC.gov